488 related articles for article (PubMed ID: 31811540)
1. Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era.
Safar-Boueri L; Piya A; Beck LH; Ayalon R
Pediatr Nephrol; 2021 Jan; 36(1):19-30. PubMed ID: 31811540
[TBL] [Abstract][Full Text] [Related]
2. [Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy].
Tang XL; DU YY; Yu J; Ye T; Zhu H; Chen YF; Li XH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Apr; 45(2):235-244. PubMed ID: 37157070
[TBL] [Abstract][Full Text] [Related]
3. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
L'Imperio V; Pieruzzi F; Sinico RA; Nebuloni M; Granata A; Smith A; Radice A; Pagni F
J Nephrol; 2018 Aug; 31(4):543-550. PubMed ID: 29626294
[TBL] [Abstract][Full Text] [Related]
4. Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings.
Kaya B; Paydas S; Balal M; Eren Erdogan K; Gonlusen G
Int J Clin Pract; 2021 Apr; 75(4):e13855. PubMed ID: 33249733
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of M
Gong Z; Yuan S; Zhu X; Wang Y; Yu F; Yang D; Xu X; Liu H; Li J; Sun L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun; 45(6):693-700. PubMed ID: 32879127
[TBL] [Abstract][Full Text] [Related]
6. Membranous nephropathy: integrating basic science into improved clinical management.
Cattran DC; Brenchley PE
Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy.
Iwakura T; Ohashi N; Kato A; Baba S; Yasuda H
PLoS One; 2015; 10(9):e0138841. PubMed ID: 26393352
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy].
Kakhsurueva PA; Kamyshova ES; Bobkova IN; Stavrovskaya EV; Rudenko TE; Andreeva EY
Ter Arkh; 2023 Aug; 95(6):462-467. PubMed ID: 38158964
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
[TBL] [Abstract][Full Text] [Related]
10. Effects of phospholipase A
Yeter HH; Isik Gonul I; Eraslan E; Karacalik C; Ogut B; Guz G
Clin Exp Nephrol; 2021 May; 25(5):488-500. PubMed ID: 33459908
[TBL] [Abstract][Full Text] [Related]
11. Features of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A in malignancy-associated membranous nephropathy.
Zhang C; Zhang M; Chen D; Ren Q; Xu W; Zeng C; Qin W; Liu Z
J Clin Pathol; 2019 Oct; 72(10):705-711. PubMed ID: 31243053
[TBL] [Abstract][Full Text] [Related]
12. Membranous Nephropathy: Core Curriculum 2021.
Alsharhan L; Beck LH
Am J Kidney Dis; 2021 Mar; 77(3):440-453. PubMed ID: 33487481
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans.
Lwezaula BF; Ameh OI; Ekrikpo UE; Botha FC; Okpechi-Samuel US; Wearne N; Ronco P; Bello AK; Okpechi IG
BMC Nephrol; 2021 Jan; 22(1):15. PubMed ID: 33413188
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers to detect membranous nephropathy in Chinese patients.
Lin L; Wang WM; Pan XX; Xu J; Gao CN; Zhang W; Ren H; Xie JY; Shen PY; Xu YW; Ni LY; Chen N
Oncotarget; 2016 Oct; 7(42):67868-67879. PubMed ID: 27634909
[TBL] [Abstract][Full Text] [Related]
15. Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia.
Shirai S; Akiyama S; Kamijo-Ikemori A; Suzuki T; Ichikawa D; Koike J; Kimura K; Shibagaki Y
CEN Case Rep; 2020 Feb; 9(1):65-73. PubMed ID: 31705303
[TBL] [Abstract][Full Text] [Related]
16. Membranous nephropathy: not just a disease for adults.
Ayalon R; Beck LH
Pediatr Nephrol; 2015 Jan; 30(1):31-9. PubMed ID: 24375012
[TBL] [Abstract][Full Text] [Related]
17. PLA2R and THSD7A: Disparate Paths to the Same Disease?
Beck LH
J Am Soc Nephrol; 2017 Sep; 28(9):2579-2589. PubMed ID: 28674044
[TBL] [Abstract][Full Text] [Related]
18. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
Zaghrini C; Seitz-Polski B; Justino J; Dolla G; Payré C; Jourde-Chiche N; Van de Logt AE; Booth C; Rigby E; Lonnbro-Widgren J; Nystrom J; Mariat C; Cui Z; Wetzels JFM; Ghiggeri G; Beck LH; Ronco P; Debiec H; Lambeau G
Kidney Int; 2019 Mar; 95(3):666-679. PubMed ID: 30784662
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous Remission of Thrombospondin Type-1 Domain-Containing-Associated Membranous Nephropathy.
Watanabe S; Suzuki T; Han W; Nakata M; Koitabashi K; Ichikawa D; Kamijo-Ikemori A; Koike J; Shibagaki Y
Intern Med; 2021 Oct; 60(19):3125-3128. PubMed ID: 33840692
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Primary Membranous Nephropathy.
Gu Y; Xu H; Tang D
Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33808418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
